Media

All news HealthCap news Interviews

December 02, 2018

Aprea Therapeutics Presents Results From Phase Ib/II Clinical Study of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego

December 01, 2018

Oncopeptides presents first interim data from the ongoing combination trial ANCHOR with melflufen at the 60th American Society of Hematology Meeting

November 30, 2018

US Court of Appeals denies Actavis’s petition for rehearing regarding validity of the Zubsolv® patent

November 30, 2018

Vicore Pharma’s Board of Directors has resolved on a directed share issue of around SEK 160 million to finance the continued development of the drug development programs VP01 and VP02

November 28, 2018

Targovax is invited to present at upcoming investor and industry conferences

November 27, 2018

Altimmune Appoints Vipin K. Garg, Ph.D. as its New President and Chief Executive Officer

November 27, 2018

BioClin Therapeutics Announces Name Change to Rainier Therapeutics

November 22, 2018

Oncorena raises SEK 14.5 million to prepare for clinical study in advanced kidney cancer

November 20, 2018

Strongbridge Biopharma plc Announces Presentation of New Data Comparing the In Vitro Effects of Levoketoconazole, the Active Ingredient in RECORLEV™, and Ketoconazole on Human Cortisol Production

November 19, 2018

BONESUPPORT™ – POSITIVE RESULTS FROM THE CERTiFy STUDY COMPARING CERAMENT®|BONE VOID FILLER WITH AUTOGRAFT